Washington, DC Hosting Bird Flu Summit for Businesses

Share Article

Business leaders will have access to bird flu experts from around the world to address pandemic prevention, preparedness, response and recovery February 27-28, 2006, at Washington, DC's first Bird Flu Summit.

Bird flu experts will focus on the business-related issues in pandemic prevention, preparedness, response and recovery at Washington, DC's first Bird Flu Summit to be held February 27-28, 2006 at the Hyatt Regency Crystal City near Reagan National Airport.

The 2-day event, featuring public sector and private sector leaders addressing the bird flu threat, will be co-chaired by international healthcare advisor Dr. Joseph Agris (http://www.flulab.com), and will present collective approaches to pandemic influenza preparedness and business continuity planning.

Special emphasis will be placed on identifying the responsibilities of various stakeholders in order to improve communications, coordination and collaboration worldwide.

Dr. Agris will also outline proposed measures for Iraq, where bird flu deaths have been recently reported.

Confirmed speakers and topics include:

Overview

Koos van der Velden

Chairman

European Influenza Surveillance Scheme

Country Report and Situation Updates

Dr. Huseyin Avni Sahin

Chief Physician

Van Yuzuncu Yil Research Hopital, Turkey

Dr. Mircea Ioan Popa

Associate Professor in Microbiology

Adviser to the Minister of Health

Ministry of Health, Romania

Avian influenza: Animals, Man and Pathogen

Alex Thiermann

President

Terrestrial Animal Health Code Commission

World Organization for Animal Health ( OIE )

Bird Flu Transmission to Humans May Be Higher Than Thought

Anna Thorson, M.D., Ph.D

Researcher

Division of International Health

Department of Public Health Sciences

Karolinska Institute, Stockholm, Sweden.

The Epidemiology and Evolution of Human and Animal Influenza Viruses    

Dr. Alan J. Hay

Director, World Influenza Centre

National Institute for Medical Research, London

Surveillance and Data Management

Michael Wagner, M.D., Ph.D.

Director

Real-time Outbreak and Disease Surveillance ( RODS ) Laboratory

Veronica Urdaneta

State Epidemiologist and Division Director,

Bureau of Epidemiology

Pennsylvania Department of Health

Marion A. Kainer MD, MPH, FRACP

Medical Epidemiologist

Communicable and Environmental Disease Services

Tennessee Deptartment of Health

Dr. Patricia Somsel

Director

Division of Infectious Disease, Bureau of Laboratories

Michigan Department of Community Health

Dr. Andrew Miller

Syndrome Reporting Information System ( SYRIS ) Product Manager

ARES Corporation

Preparing Communities Strategies; Local Partnership and Participation

Tim Stephens

President

Rescobie Associates, Inc.

Sheriff James Hagy

Office of Sheriff

Law Enforcement Center

Frederick, MD

John Thompson

Deputy Executive Director

National Sheriffs Association

Critical Infrastructure Continuity    

Dr. Tom McGinn

Sector Specialist

Public Health, Food and Agriculture

Department of Homeland Security

Vaccine Delivery

John Iskander

Project officer

Vaccine Adverse Events Reporting System

CDC

Dr. Andrea Gambotto

Asst. Professor of Surgery

Co-director, Vector Core Facility

University of Pittsburgh School of Medicine

The Aethlon Hemopurifier as a Treatment for Drug Resistant Avian Flu

James A. Joyce

Chairman, CEO

Aethlon Medical, Inc.

Emergency Response and Hospital/Health Care Coordination

John O. Davies-Cole

State Epidemiologist

Washington DC Department of Health

Dr. Sandra Schneider

Professor and Chair

University of Rochester

Playing Ostrich or Talking Turkey: Pre-Pandemic Risk Communication Strategies    

Jody Lanard M.D.

Risk Communication Specialist

Princeton, NJ

The Peter Sandman Risk Communication

Poultry Farms: The Frontline Fight Against Avian Flu    

Dr. Bruce N. Stewart-Brown

Vice President

Food Safety and Quality

Perdue Farms

Dr. Steve Roney

Director

Veterinary Services

Gold Kist Inc.

Benefit-Risk Assessment: Public Health, Industry and Regulatory Perspectives    

Brian T. Yeh

Legislative Attorney

American Law Division

Congressional Research Service

Doug Colwell

Director of Immunobiology

Antigen Express, Inc. ( Generex )

Stephen Aldrich

CEO

Bio Economic Research Associates (BIO-ERA)

The Effect of a Bird Flu Pandemic on the U.S. Life Insurance Industry

Dr. Steven Weisbart

Economist

Insurance Information Institute

Prevention Education Efforts and Risk Communication

Caroline Smith DeWaal

Director for Food Safety

Center for Science in the Public Interest

Antiviral Agents

C. Shane Arnold, Ph.D.

Director, Peramivir Development

Research Biologist II

BioCryst Pharmaceuticals, Inc.

Legal Considerations: Immunizing Vaccine Manufacturers

Jason Waite

Partner

Alston and Bird

Christopher Milne

Assistant Director

Tufts Center for the Study of Drug Development

John Clerici

Partner

Mckenna Long Aldridge

Prospective speakers and attendees may register by calling the conference organizer, NewFields/USA, at 1-202-536-5000 or visiting http://www.new-fields.com/birdflu.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Simmons
Visit website